Calando Pharmaceuticals focuses on creating targeted therapeutics for the development of nanoparticle drug formulations.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Pasadena
State: California
Zip:
Country: United States
Calando Pharmaceuticals is a biopharmaceutical company focused on creating targeted therapeutics using its patented and proprietary cyclodextrin-based polymer technologies for the development of nanoparticle drug formulations. Calando’s initial emphasis has been to bring targeted siRNA and small molecule therapeutics to the clinic for oncology applications; however, the technologies are not limited to these classes of molecules and are applicable to a very broad range of therapeutic entities and diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2011 | Venture Round | 1 | $1M |
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals |
4/2006 | Venture Round | 1 | $10M |
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|